Showing 4851-4860 of 5646 results for "".
- STAAR Surgical’s EVO Viva Presbyopia Correcting Lens Receives CE Mark Approvalhttps://modernod.com/news/staar-surgicals-evo-viva-presbyopia-correcting-lens-receives-ce-mark-approval/2477977/STAAR Surgical announced that its EVO Viva presbyopia correcting implantable collamer lens (ICL) has been approved for sale. STAAR received CE Mark approval of the presbyopic indication for its EVO+ Visian ICL with Aspheric (EDOF) Optic, commercially marketed as “EVO Viva,” from its European Noti
- Apellis Completes Enrollment in Two Phase 3 Studies of Pegcetacoplan in Patients with Geographic Atrophy (GA)https://modernod.com/news/apellis-completes-enrollment-in-two-phase-3-studies-of-pegcetacoplan-in-patients-with-geographic-atrophy-ga/2477978/Apellis Pharmaceuticals announced that it completed enrollment in the phase 3 DERBY and OAKS studies investigating intravitreal pegcetacoplan (APL-2), a targeted C3 therapy, for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). GA causes blind
- VisionCare Names Thomas Ruggia as New Chief Executive Officerhttps://modernod.com/news/visioncare-names-thomas-ruggia-as-new-chief-executive-officer/2477973/VisionCare announced that Thomas Ruggia has been appointed as the company’s new Chief Executive Officer, effective July 6, 2020. VisionCare provides the only FDA approved surgical treatment for macular degeneration, the telescope implant and CentraSight treatment program. “We’re thrilled
- Patrick F. Williams Appointed Chief Financial Officer of Staar Surgicalhttps://modernod.com/news/patrick-f-williams-appointed-chief-financial-officer-of-staar-surgical/2477969/Staar Surgical announced that Patrick F. Williams has joined the company as Chief Financial Officer, effective today. Mr. Williams is reporting to Caren Mason, President and Chief Executive Officer. His appointment is part of a planned transition following Deborah Andrews’ previously announced re
- Gilead’s Veklury Gains Conditional EU Approval for Treatment of COVID-19https://modernod.com/news/gileads-veklury-gains-conditional-eu-approval-for-treatment-of-covid-19/2477970/Gilead Sciences said Friday that the European Commission granted conditional approval to Veklury (remdesivir) for the treatment of SARS-CoV-2 infection. The company noted that the clearance, which was based on a rolling review that began in April, follows a
- Retinopathy Risk Increased in T2DM After Cataract Surgeryhttps://modernod.com/news/retinopathy-risk-increased-in-t2dm-after-cataract-surgery/2477965/People with type 2 diabetes are more likely to develop diabetic retinopathy (DR) after cataract surgery, according a new population-based study, according to a Reuters report. Over six years of follow-up, the adjusted risk of retino
- American Academy of Ophthalmology to Launch its First Open Access Journal in Early 2021https://modernod.com/news/american-academy-of-ophthalmology-to-launch-its-first-open-access-journal-in-early-2021/2477962/The American Academy of Ophthalmology announced plans to expand the Ophthalmology family of journals to include Ophthalmology Science, an online open access journal focused on publishing preclinical development, phase 1 and 2 clinical trials, laboratory-based work, ophthalmology
- Global COVID-19 Prevention Trial of Hydroxychloroquine to Resumehttps://modernod.com/news/global-covid-19-prevention-trial-of-hydroxychloroquine-to-resume/2477960/A global trial designed to test whether the anti-malaria drugs hydroxychloroquine and chloroquine can prevent infection with COVID-19 is to restart after being approved by British regulators, according to a Reuters report. The Medic
- Oculight Launches US Subsidiary OCU L&Chttps://modernod.com/news/oculight-launches-us-subsidiary-ocu-lc/2477956/Oculight announced the launch of OCU L&C, a fully-owned U.S. subsidiary. OCU L&C will focus on the commercialization of its products in the U.S. Oculight is an ophthalmic medical device developer based in Korea founded in 2017 by Dr.
- Remdesivir, the First Coronavirus Drug, Gets a Price Taghttps://modernod.com/news/remdesivir-the-first-coronavirus-drug-gets-a-price-tag/2477953/Remdesivir, the first drug shown to be effective against the coronavirus, will be distributed under an unusual agreement with the federal government that establishes nonnegotiable prices and prioritizes American patients, health officials announced on Monday, accordin